<DOC>
	<DOCNO>NCT01295008</DOCNO>
	<brief_summary>The purpose study ass whether patient classic form Fabry disease significantly less androgenic alopecia ( male pattern baldness ) .</brief_summary>
	<brief_title>Androgenetic Alopecia Fabry Disease</brief_title>
	<detailed_description>Objectives : To test hypothesis adult male classic form Fabry disease significantly low incidence androgenic alopecia match control . Study Population : 120 patient age 20-64 Fabry disease GLA mutations alpha-galactosidase A activity associate residual enzyme activity non-Fabry male control age range number non-Fabry control . Design : This cross-sectional study compare prevalence androgenic alopecia two group subject . Outcome Measures : The level outcome androgenic alopecia frontal androgenetic alopecia oppose vertex frontal vertex androgenetic alopecia .</detailed_description>
	<mesh_term>Fabry Disease</mesh_term>
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<criteria>Male patient Fabry disease age 2064 year old . Healthy male control age 2064 year old GLA gene mutation associate classic form Fabry disease alphagalactosidase A activity essentially zero Patients freely agree participate study understand nature , risk benefit study give write informed consent .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Fabry disease</keyword>
	<keyword>Male pattern baldness</keyword>
	<keyword>Alopecia</keyword>
	<keyword>GLA gene mutation</keyword>
	<keyword>Alpha-galactosidase A</keyword>
</DOC>